GGrantIndex
← Search

PREVENTING HEPATITIS B INFECTION IN LIVER TRANSPLANTATION

$0M01FY2000RRNIH

University Of California San Francisco, San Francisco CA

Investigators

Linked publications & trials

Abstract

The goals of the study are to prove the safety and efficacy of transfusion of hepatitis B immune plasma (HBIP). Liver transplant patients infected with HBV will receive 100ml of HBIP at monthly intervals. A total of 12 patients per year are estimated to receive this treatment. Pretransfusion serum specimens will be collected and sent to Dr. Vyas' laboratory.

View original record on NIH RePORTER →